Actively Recruiting

Phase Not Applicable
Age: 18Years - 90Years
All Genders
Healthy Volunteers
NCT03675412

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Led by Wills Eye · Updated on 2025-11-14

80

Participants Needed

1

Research Sites

417 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.

CONDITIONS

Official Title

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Who Can Participate

Age: 18Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 90 years
  • Diagnosis of primary open angle glaucoma (mild, moderate, or advanced)
  • Healthy subjects with no eye disease
Not Eligible

You will not qualify if you...

  • Diseases affecting OCTA results, ophthalmic or systemic
  • Greater than moderate cataract
  • Nystagmus
  • Inability to look at target
  • Macular degeneration other than mild drusen or pigmentary changes
  • Diabetic retinopathy
  • Neovascular glaucoma or non-glaucoma optic neuropathies
  • Current macular edema, prior laser to retina, inflammatory retinopathy or choroidopathy
  • Keratoconus, corneal ectasia, central corneal scarring
  • Rheumatologic diseases or Raynaud's phenomena
  • Pregnant and lactating women
  • Mental illness or alcohol addiction
  • Pre-existing bladder symptoms, cardiac disease or sleep disorder
  • Refractive spherical diopter greater than 5 or cylinder greater than 3
  • Possible tolerance to caffeine (drinking more than 1 cup coffee per day)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Wills Eye Glaucoma Service

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

Loading map...

Research Team

M

M. Reza Razeghinejad, MD

CONTACT

J

Jeanne Molineaux, COA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here